Clinical Trial: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772401) titled 'Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder' on July 22, 2025.

Brief Summary: This clinical trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with social anxiety disorder (SAD). The study addresses the following key research questions:

* Does taVNS demonstrate preliminary clinical efficacy in the treatment of SAD?

* What adverse events may occur during taVNS treatment, and what is the treatment compliance of the subjects?

Study Start Date: May 05

Study Type: INTERVENTIONAL

Condition: Social Anxiety Disorder Soci...